Krishna Institute of Medical Sciences Limited Stock Price Today (NSE: KIMS)

Krishna Institute of Medical Sciences Limited

758.40+2.90 (+0.38%)
Market Closed

Fundamental Score

...

Krishna Institute of Medical Sciences Limited Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Krishna Institute of Medical Sciences Limited share price today is 758.40, up +0.38% on NSE/BSE as of 1 September 2026. Krishna Institute of Medical Sciences Limited (KIMS) is a Large-cap company in the Hospital sector with a market capitalisation of 33.95K (Cr). The 52-week high for KIMS share price is 858.00 and the 52-week low is 575.80. At a P/E ratio of 166.00x, KIMS is currently trading above its industry average P/E of 48.79x. The company has a Return on Equity (ROE) of 11.01% and a debt-to-equity ratio of 1.44.

Krishna Institute of Medical Sciences Limited Share Price Chart — NSE/BSE Historical Performance

No data
High
827.95
Low
758.40
Volume
6.4L
Change
+2.14%

Krishna Institute of Medical Sciences Limited share price chart: 2.14% return over the past month. 52-week high ₹858.00, 52-week low ₹575.80.

Krishna Institute of Medical Sciences Limited — Last 10 Trading Days

DateOpenHighLowCloseVolume
770.00783.40765.50772.5011.19L (Cr)
800.00808.90800.00805.502.18L (Cr)
809.90827.95804.10809.104.14L (Cr)
800.00811.00799.10807.552.68L (Cr)
810.50814.55800.00803.954.60L (Cr)
819.00819.50806.10813.058.52L (Cr)
811.15822.50804.10819.504.42L (Cr)
803.10826.80803.10811.1018.02L (Cr)
803.00819.80801.00808.605.04L (Cr)
795.90815.00783.15802.156.56L (Cr)

Krishna Institute of Medical Sciences Limited — Last 12 Months Price History

MonthOpenHighLowCloseChange
805.95827.95765.50772.50-4.15%
818.00858.00779.05804.70-1.63%
759.50834.70725.40814.60+7.25%
672.00791.15663.00758.85+12.92%
630.10691.90613.00666.70+5.81%
712.35735.00610.80621.50-12.75%
593.00757.50578.60745.05+25.64%
610.50667.15575.80603.75-1.11%
690.25712.00599.85608.60-11.83%
724.50733.45653.65685.10-5.44%
700.15742.80676.80721.05+2.99%
721.50772.00697.30700.15-2.96%

Returns & Performance

Poor

Return on Equity (ROE)

11.01%

Profit generated per ₹1 of shareholder equity

Poor

Return on Capital (ROCE)

9.35%

Returns generated on total capital deployed

Excellent

Oper. Profit Margin (5Y Avg)

27.04%

Average operating profit margin over 5 years

Dividend Yield

0.00%

Annual dividend as % of current share price

Krishna Institute of Medical Sciences Limited Valuation Check

Poor

Price to Earnings (P/E)

166.00x

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

48.79x

Average P/E of all peers in this sector

Market-cap Classification
Large-cap
Established & liquid; typically steadier returns.

Shareholding Pattern

Excellent

Promoter Holding

34.11%

% shares held by company founders/management

Good

FII Holding

14.57%

% shares held by foreign institutional investors

Excellent

DII Holding

32.50%

% held by domestic mutual funds, LIC, banks

Poor

Promoter Pledged %

10.26%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Poor

Profit Growth (Quarterly YoY)

-47.20%

Net profit growth vs same quarter last year

Excellent

Revenue Growth (Quarterly YoY)

35.33%

Revenue growth vs same quarter last year

Excellent

Revenue Growth (5-Year CAGR)

24.04%

Compounded annual revenue growth over 5 years

Poor

EPS Growth (5-Year CAGR)

-25.83%

Earnings per share growth over 5 years

Poor

Net Profit Growth (5-Year CAGR)

3.71%

Compounded annual net profit growth over 5 years

Balance Sheet Health

Poor

Debt to Equity Ratio

1.44x

Total debt ÷ equity. Below 0.5 = financially healthy

Average

Interest Coverage Ratio

2.64x

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

-1.46K (Cr)

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Krishna Institute of Medical Sciences Limited Fundamental Analysis & Valuation Benchmarking

Educational evaluation of KIMS across key market metrics for learning purposes.

Positive Indicators

4 factors identified

Strong Operating Margins (27.04%)

Observation: Healthy 5-year operating margins indicate pricing power and cost control.

Analysis: OPM >15% suggests operational efficiency and competitive advantages.

Strong Revenue Growth (35.33%)

Observation: Healthy sales growth indicates market demand and execution capability.

Analysis: Revenue growth >15% suggests strong market position and growth potential.

Consistent Growth Track Record (24.04% CAGR)

Observation: Strong 5-year sales compound annual growth rate.

Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.

Strong Institutional Confidence (FII+DII: 47.07%)

Observation: Significant professional investor participation.

Analysis: High institutional holding often signals thorough due diligence.

Risk Factors

10 factors identified

Suboptimal ROCE (9.35%)

Observation: Returns on capital employed are below expectations.

Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.

Premium Valuation Risk (P/E: 166.00x)

Observation: High valuation multiples may limit upside potential.

Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.

High Price-to-Book Ratio (15.11x)

Observation: Trading at significant premium to book value.

Analysis: High P/B ratios may indicate overvaluation relative to asset base.

Profit Decline Concern (-47.20%)

Observation: Significant year-over-year profit contraction observed.

Analysis: Declining profitability requires investigation into underlying causes.

Weak Earnings Growth (-25.83% CAGR)

Observation: Below-average 5-year EPS growth performance.

Analysis: Low EPS growth may not keep pace with inflation.

Stagnant Profit Growth (3.71% CAGR)

Observation: Limited 5-year profit growth trajectory.

Analysis: Low profit growth may indicate scalability challenges or market maturity.

Elevated Debt Levels (D/E: 1.44)

Observation: High leverage increases financial risk and interest burden.

Analysis: High debt-to-equity ratios require monitoring of debt servicing capability.

Liquidity Concerns (Current Ratio: 0.76)

Observation: Current assets may not adequately cover short-term liabilities.

Analysis: Current ratio <1.0 raises working capital concerns.

Negative Free Cash Flow (₹-1459.04 Cr over 5Y)

Observation: Cash outflows exceed inflows.

Analysis: Negative FCF requires analysis of capital expenditure cycle.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.

Krishna Institute of Medical Sciences Limited vs Hospital Peers

Peer Comparison - Hospital

Compare Krishna Institute of Medical Sciences Limited with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
13.9/100
758
₹33947.05
166.0
Average
11.01%
Average
9.35%
Poor
1.4
Average
3.71%
Average
24.04%
Excellent
0.00%
62.1/100
8817
₹128448.55
61.5
Average
21.95%
Excellent
19.28%
Good
0.6
Good
66.81%
Excellent
19.03%
Excellent
0.22%
56.9/100
1014
₹107422.79
73.7
Average
14.33%
Average
13.43%
Average
0.3
Excellent
27.30%
Excellent
0.18%
56.8/100
917
₹73687.64
70.3
Average
11.08%
Average
12.83%
Average
0.3
Excellent
17.76%
Excellent
0.10%
37.2/100
818
₹71917.90
225.7
Average
9.70%
Poor
11.35%
Average
0.2
Excellent
21.31%
Excellent
-11.61%
Poor
0.61%
68.3/100
1803
₹41592.95
51.0
Average
19.74%
Good
14.53%
Average
1.1
Average
25.05%
Excellent
0.22%
59.9/100
1443
₹35993.93
64.7
Average
15.15%
Good
16.85%
Good
0.3
Excellent
0.04%
48.5/100
503
₹15618.15
105.3
Average
6.84%
Poor
10.16%
Average
0.1
Excellent
0.00%
65.5/100
1459
₹15270.28
53.5
Average
17.86%
Good
18.10%
Good
0.0
Excellent
0.23%
60/100
318
₹9829.95
52.3
Average
13.41%
Average
15.25%
Good
0.3
Excellent
0.07%
42.7/100
714
₹9663.25
424.2
Average
1.22%
Poor
7.43%
Poor
0.7
Good
20.22%
Excellent
0.00%

Krishna Institute of Medical Sciences Limited PE Ratio History

Historical price-to-earnings ratio for KIMS — last 5 years

YearEPS (₹)Price (₹)P/E Ratio
FY 20259.61₹608.6063.3x
FY 20247.75₹598.0077.2x
FY 20238.41₹1979.20235.5x
FY 20228.38₹1547.30184.7x

P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.

Krishna Institute of Medical Sciences Limited Quarterly Performance

Latest quarterly metrics for KIMS — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

35.33%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

-47.20%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

24.04%

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

3.71%

Compounded annual net profit growth over 5 years

Krishna Institute of Medical Sciences Limited Technical Indicators

SMA 50, SMA 200, RSI and volume signals for KIMS — calculated from daily price history

54RSI 14
Neutral — RSI 54

Momentum is balanced — neither overbought nor oversold.

SMA 50
803
▼ Price below SMA 50 — Short-term bearish
SMA 200
708
▲ Price above SMA 200 — Long-term uptrend
30-Day Avg Volume
580K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

Krishna Institute of Medical Sciences Limited Financial Statements

Annual income statement, balance sheet and cash flow for Krishna Institute of Medical Sciences Limited (KIMS) — sourced from NSE/BSE filings.

Financial Results & Statements

Latest quarterly, annual and period-wise financial data for Krishna Institute of Medical Sciences Limited

Loading latest quarterly results...

About KIMS (Krishna Institute of Medical Sciences Limited)

Krishna Institute of Medical Sciences Ltd is a beacon of hope and healing, a multi-specialty hospital group renowned for its advanced medical infrastructure and compassionate patie...nt care. Towering structures house state-of-the-art operating theaters equipped with robotic surgical systems, cutting-edge diagnostic imaging centers, and specialized intensive care units designed to meet the diverse needs of critically ill patients. Stepping inside, one is immediately enveloped in an atmosphere of clinical precision blended with human empathy, as highly trained medical professionals collaborate seamlessly to deliver personalized treatment plans. The hospital's corridors resonate with the quiet hum of sophisticated medical equipment, a testament to its commitment to embracing technological advancements for improved patient outcomes. Each ward is meticulously maintained, offering a sanctuary of comfort and tranquility for those on their journey to recovery. Within KIMS, a constellation of medical specialties thrives, each department a center of excellence dedicated to pushing the boundaries of medical knowledge. Neurological disorders find sophisticated diagnosis and treatment within specialized units, supported by advanced neuro-imaging and rehabilitation programs. The heart center pulsates with innovation, offering a comprehensive range of cardiac services from minimally invasive procedures to complex heart transplants. Respiratory ailments are addressed with cutting-edge interventions, including advanced diagnostics, interventional pulmonology, and lung transplantation. The digestive health institute stands as a leader in gastrointestinal care, performing intricate surgeries and offering advanced treatments for liver and pancreatic diseases. KIMS embraces holistic healthcare, incorporating preventative medicine, wellness programs, and patient education to empower individuals to take control of their health. At the heart of KIMS lies a dedicated team of physicians, surgeons, nurses, and support staff united by a common mission: to provide exceptional healthcare with unwavering compassion. These highly skilled professionals are not only experts in their respective fields but also empathetic caregivers who understand the importance of human connection in the healing process. Every patient is treated with dignity and respect, their individual needs carefully considered in the development of a tailored treatment plan. KIMS fosters a culture of continuous learning and improvement, encouraging its staff to participate in ongoing research and training programs to stay at the forefront of medical innovation. This commitment to excellence ensures that patients receive the highest quality care, delivered with empathy and precision.

Company Details

Symbol:KIMS
Industry:Hospital
Sector:Hospital

Key Leadership

Dr. Bhaskara Rao Bollineni
Founder, MD & Executive Chairman
Dr. Abhinay Bollineni
CEO & Executive Director
Mr. Sachin Ashok Salvi
Chief Financial Officer

KIMS Share Price: Frequently Asked Questions

What is the current share price of Krishna Institute of Medical Sciences Limited?

Krishna Institute of Medical Sciences Limited (KIMS) trades at ₹758.40 on NSE and BSE. Market cap ₹33.95K (Cr). Educational data only.

What is the P/E ratio of Krishna Institute of Medical Sciences Limited?

Krishna Institute of Medical Sciences Limited has a P/E of 166.00x vs industry average 48.79x.

What is the Bull Run score for Krishna Institute of Medical Sciences Limited?

Krishna Institute of Medical Sciences Limited has a Bull Run score of 13.9/100 based on 25+ financial parameters.

Does Krishna Institute of Medical Sciences Limited pay dividends?

Krishna Institute of Medical Sciences Limited has a dividend yield of 0.00%. Past dividends don't guarantee future payments.

What is the ROE of Krishna Institute of Medical Sciences Limited?

Krishna Institute of Medical Sciences Limited has ROE of 11.01%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Krishna Institute of Medical Sciences Limited?

Krishna Institute of Medical Sciences Limited has debt-to-equity of 1.44.

Is Krishna Institute of Medical Sciences Limited a good investment?

Bull Run gives Krishna Institute of Medical Sciences Limited a score of 13.9/100. This is not investment advice — consult a SEBI-registered advisor.